Lachen (Switzerland)

Type: City
Name: Lachen (Switzerland)
Country: Switzerland
Latitude: 47.189999
Longitude: 8.84
population: 6,879
First reported Oct 27 2014 - Updated Oct 28 2014 - 2 reports

Octapharma Announces Octagam® 10% Now Available for Ordering in U.S.

today announced that is available for ordering within the U.S.The U.S. Food and Drug Administration (FDA) has approved Octagam“We are extremely pleased to announce U.S. product availability for Octagam 10%,” said Octapharma USA President Flemming Nielsen. ... [Published Industrial Info Financials - Oct 27 2014]
First reported Sep 26 2014 - Updated Sep 26 2014 - 1 reports

Stehlin parent restructures European ink sites

Hubergroup is rationalising its European set-up by merging its German operations and closing its factory in Lachen, Switzerland.Ward: we need a global approachMichael Huber München and Hostmann-Steinberg, the firm’s largest European operations will be ... [Published Print Week - Sep 26 2014]
First reported Aug 06 2014 - Updated Aug 06 2014 - 1 reports

European Commission publishes approval of Octapharma’s human cell line recombinant FVIII (Nuwiq®) across all age groups in haemophilia A

LACHEN, Switzerland--(BUSINESS WIRE)--European Commission publishes approval of Octapharma’s human cell line recombinant FVIII (Nuwiq®) across all age groups in haemophilia A for the treatment and prophylaxis of bleeding. ... [Published Business Wire Health News - Aug 06 2014]
First reported May 27 2014 - Updated May 28 2014 - 1 reports

Octapharma sponsors symposium “Spotlight on the human factor: building a foundation for the future of haemophilia A management" at 2014 WFH World Congress in Melbourne, Australia

LACHEN, Switzerland--(BUSINESS WIRE)--Octapharma sponsors symposium “Spotlight on the human factor: building a foundation for the future of haemophilia A management" at 2014 WFH World Congress in Melbourne, Australia ... [Published Business Wire Health News - May 27 2014]
First reported May 26 2014 - Updated May 27 2014 - 1 reports

European Medicines Agency (EMA) adopts positive opinion on Octapharma’s human cell line recombinant human FVIII (Nuwiq®) in children and adults with haemophilia A

LACHEN, Switzerland--(BUSINESS WIRE)--European Medicines Agency (EMA) adopts positive opinion on Octapharma’s human cell line recombinant human FVIII (Nuwiq®) in children and adults with haemophilia A ... [Published Business Wire Health News - May 26 2014]

More Content

All (6) | News (3) | Reports (0) | Blogs (3) | Audio/Video (0) | Fact Sheets (0) | Press Releases (0)
sort by: Date | Relevance
Octapharma Announces Octagam® 10% Now Available... [Published Industrial Info Financials - Oct 27 2014]
Octapharma Announces Octagam® 10% Now Available... [Published Myrtle Beach Sun News - Oct 27 2014]
Stehlin parent restructures European ink sites [Published Print Week - Sep 26 2014]
European Commission publishes approval of Octap... [Published Business Wire Health News - Aug 06 2014]
Octapharma sponsors symposium “Spotlight on the... [Published Business Wire Health News - May 27 2014]
European Medicines Agency (EMA) adopts positive... [Published Business Wire Health News - May 26 2014]
1
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
European Commission publishes approval of Octap... [Published Business Wire Health News - Aug 06 2014]
LACHEN, Switzerland--(BUSINESS WIRE)--European Commission publishes approval of Octapharma’s human cell line recombinant FVIII (Nuwiq®) across all age groups in haemophilia A for the treatment and prophylaxis of bleeding. ...
Octapharma sponsors symposium “Spotlight on the... [Published Business Wire Health News - May 27 2014]
LACHEN, Switzerland--(BUSINESS WIRE)--Octapharma sponsors symposium “Spotlight on the human factor: building a foundation for the future of haemophilia A management" at 2014 WFH World Congress in Melbourne, Australia ...
European Medicines Agency (EMA) adopts positive... [Published Business Wire Health News - May 26 2014]
LACHEN, Switzerland--(BUSINESS WIRE)--European Medicines Agency (EMA) adopts positive opinion on Octapharma’s human cell line recombinant human FVIII (Nuwiq®) in children and adults with haemophilia A ...
1
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.